课题基金 / 基金详情

Ghost tangle elimination mechanism in the CA1 of parkinsonism-dementia complex of Guam

Ghost tangle elimination mechanism in the CA1 of parkinsonism-dementia complex of Guam
关岛帕金森痴呆症CA1区的鬼魂缠结消除机制
批准号:
12680742
负责人:
OYANAGI Kiyomitsu
金额:
$1.86万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

OYANAGI Kiyomitsu的其他基金

相似基金

相关文献

中文摘要
翻译
用免疫组织化学和免疫电子显微镜观察了帕金森病痴呆复合体CA1区鬼影缠结的消除机制。神经元中的神经原纤维缠结主要由粗大的螺旋细丝(PHF)组成,而鬼影缠结主要由直管(STS)组成。免疫组织化学显示星形细胞突起与幽灵缠结紧密交织。免疫电子显微镜下,星形细胞胶质细丝与幽灵缠结的STS混杂在一起。然而,小胶质细胞的参与并不显著。在溶酶体中没有观察到神经原纤维缠结,包括PHF和STS。结果表明,幽灵缠结被星形胶质细胞消除。然而,由于死后自溶的改变,星形胶质细胞的质膜在这些观察中并不清楚。因此,消除星形胶质细胞内或细胞外空间的实际位置并不清楚。为了克服这一问题,使用动物和NFT脑内接种进行实验研究是不可避免的。
英文摘要
The elimination mechanism of ghost tangle was observed immunohistochemically and immunoelectron microscopically in the CA1 of the parkinsonism-dementia complex of Guam.Neurofibrillary tangles in the neurons were mainly composed of pared helical filaments (PHFs), but the ghost tangles were of straight tubules (STs). Astrocytic processes were tightly intertwined with ghost tangles in immunohistochemistry. Immunoelectronmicroscopically, astrocytic glial filaments were admixed with the ghost tangle STs. However, microglial participation was not remarkable. Neurofibrillary tangles, including PHFs and STs, were never observed in the lysosomes.The findings indicate that the ghost tangles were eliminated by the astrocytes. However, the plasma membrane of the astrocytes were not clear in these observations due to postmortem autolytic alteration. Thus the practical sites, that is, inside of astrocytes or in the extracellular space, were not clear in ghost tangle elimination.To overcome the problem, experimental study is inevitable using animals and NFT inoculation to the brains.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Oyanagi K: "Parkinsonism-dementia complex of Guam"In : Neurodegeneration. The molecular pathology of dementia and movement disorders. Ed: Olsson Y. International Society for Neuropathology. (印刷中).
Oyanagi K:“关岛帕金森病-痴呆症”,《痴呆和运动障碍的分子病理学》,Ed:Olsson Y. 国际神经病理学学会(正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oyanagi K: "Parkinsonism-dementia complex of Guam"In Neurodegeneration. The molecular pathology of dementia and movement disorders. Ed : Olsson Y. International Society for Neu-ropathology. (印刷中).
Oyanagi K:“关岛帕金森病-痴呆症综合体”,《痴呆和运动障碍的分子病理学》,Ed:Olsson Y. 国际神经病理学学会(正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oyanagi K: "Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam : specific pathological features"Journal of Neuropathology and Experimental Neurology. 60. 393-402 (2001)
Oyanagi K:“关岛进行性核上性麻痹、皮质基底节变性和帕金森痴呆症复合体中的黑质:特定病理特征”《神经病理学和实验神经病学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oyanagi K: "Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinson-dementia complex of Guam: specific pathological features"Journal of Neuropathology and Experimental Neurology. 60. 393-402 (2001)
Oyanagi K:“关岛进行性核上性麻痹、皮质基底节变性和帕金森痴呆症中的黑质:特定病理特征”《神经病理学和实验神经病学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Effect of Mg-L-threonate on alpha synuclein Tg mice
    • 批准号:
      25640028
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      OYANAGI Kiyomitsu
    • 依托单位:
    Mechanism of motor neuron death in ALS: transcription activity of ribosomal RNA gene and TDP-43
    • 批准号:
      22300117
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2010
    • 负责人:
      OYANAGI Kiyomitsu
    • 依托单位:
    Amyotrophic lateral sclerosis : on the decreased transcription activity of ribosomal RNA gene and cell degeneration
    Substantia Nigra in Progressive Supranuclear Palsy, Corticobasal Degeneration and Parkinsonism-Dementia Complex of Guam: Specific Pathological Features
    国内基金
    海外基金
    外泌体来源的CA1通过诱导巨噬细胞M2极化介导弥漫大B细胞淋巴瘤化疗耐药的机制研究
    • 批准号:
      2026JJ81932
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      冯瑜桦
    • 依托单位:
    肠道SCFA通过调控海马 CA1区神经元突触可塑性在2型糖尿病AD样变中的脑保护作用机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      田茗源
    • 依托单位:
    OsβCA1参与水稻光合作用和二氧化碳响应的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈太钰
    • 依托单位:
    HPC通过TSC1/mTOR/自噬通路调控线粒体能量代谢增加海马CA1区神经元低氧耐受的研究
    • 批准号:
      82360272
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32.2万元
    • 批准年份:
      2023
    • 负责人:
      齐瑞芳
    • 依托单位: